Patents-Review.com
🔗 Permalink
Inventor profile of:

Eugen Uhlmann

City:

Glashutten

Country:

Germany

Published Applications:

28

Last publication date:

2019-05-16

Top Assignees for applications by Eugen Uhlmann

The entities that hold a legal rights for patent applications filed by inventor Uhlmann Eugen:

Recent patent applications by Uhlmann Eugen

Eugen Uhlmann from Glashutten, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-05-16
US20190144865A1
Chemistry; metallurgy

MODIFIED TGF-BETA OLIGONUCLEOTIDE FOR USE IN A METHOD OF PREVENTING AND/OR TREATING AN OPHTHALMIC DISEASE

 #2 | 2019-02-28
US20190062743A1
Chemistry; metallurgy

Multimeric oligonucleotide compounds

 #3 | 2018-08-16
US20180230473A1
Chemistry; metallurgy

Modified TGF-beta oligonucleotides

 #4 | 2018-06-21
US20180171338A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR OLIGONUCLEOTIDE FORMULATIONS

 #5 | 2018-03-29
US20180087055A1
Chemistry; metallurgy

MODIFIED TGF-BETA2 OLIGONUCLEOTIDES

 #6 | 2018-02-01
US20180030444A1
Chemistry; metallurgy

Multimeric oligonucleotide compounds having non-nucleotide based cleavable linkers

 #7 | 2017-11-02
US20170314025A1
Chemistry; metallurgy

Modified TGF-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic disease

 #8 | 2017-07-27
US20170211065A1
Chemistry; metallurgy

Multimetric oligonucleotide compounds

 #9 | 2016-03-17
US20160076037A1
Chemistry; metallurgy

Modified TGF-beta oligonucleotides

 #10 | 2016-03-03
US20160060632A1
Chemistry; metallurgy

Modified TGF-beta2 oligonucleotides

 #11 | 2016-02-11
US20160040167A1
Chemistry; metallurgy

Modified TGF-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic disease

 #12 | 2015-11-05
US20150315588A1
Chemistry; metallurgy

Methods of delivering multiple targeting oligonucleotides to a cell using cleavable linkers

 #13 | 2015-11-05
US20150315587A1
Chemistry; metallurgy

Multimeric oligonucleotides compounds having cleavable linkers

 #14 | 2015-11-05
US20150315586A1
Chemistry; metallurgy

METHODS OF DELIVERING MULTIPLE TARGETING OLIGONUCLEOTIDES TO A CELL USING NON-NUCLEOTIDE BASED CLEAVABLE LINKERS

 #15 | 2015-11-05
US20150315585A1
Chemistry; metallurgy

Multimeric oligonucleotide compounds having non-nucleotide based cleavable linkers

 #16 | 2015-10-22
US20150299695A1
Chemistry; metallurgy

Multimeric oligonucleotides compounds

 #17 | 2015-09-03
US20150247141A1
Chemistry; metallurgy

MULTIMERIC OLIGONUCLEOTIDE COMPOUNDS

 #18 | 2014-07-08
US10193747
-

Synthetic double-stranded oligonucleotides for specific inhibition of gene expression

 #19 | 2013-06-27
US20130164333A1
Chemistry; metallurgy

Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties

 #20 | 2011-10-06
US20110244025A1
Chemistry; metallurgy

MODIFIED OLIGORIBONUCLEOTIDE ANALOGS WITH ENHANCED IMMUNOSTIMULATORY ACTIVITY

 #21 | 2011-05-19
US20110117569A1
Chemistry; metallurgy

Polymide nucleic acid derivatives, and agents and processes for preparing them

 #22 | 2010-10-14
US20100260788A1
Chemistry; metallurgy

Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties

 #23 | 2006-02-02
US20060025374A1
Chemistry; metallurgy

Oligoribonucleotide derivatives for specific inhibition of gene expression

 #24 | 2005-07-19
US9793146
-

Polyamide-oligonucleotide derivatives, their preparation and use

 #25 | 2005-07-07
US20050148017A1
Chemistry; metallurgy

Antisense oligonucleotides against tenascin for the treating of vitiligo

 #26 | 2005-06-14
US9835371
-

Polyamide nucleic acid derivatives, and agents and processes for preparing them

 #27 | 2005-04-12
US9554267
-

Antisense oligonucleotides against tenascin for treating vitiligo

 #28 | 2005-01-27
US20050020523A1
Chemistry; metallurgy

Modified antisense nucleotides complementary to a section of the human haras gene
InventorID:

1276526 ⎘